Effect of added pharmatose DCL11 on the sustained-release of metronidazole from methocel K4M and carbopol 971P NF floating matrices

Drug Development and Industrial Pharmacy

Volumn 32, Issue 8, 2006, Pages 955-965

  Cedillo Ramirez E ^a   Villafuerte Robles, L ^a   Hernandez Leon A ^b  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

Gastric retention; Matrices hydration; Matrix erosion; Sodium bicarbonate; Sustained release parameters

Indexed keywords

CARBOMER; HYDROXYPROPYLMETHYLCELLULOSE; LACTOSE; METRONIDAZOLE;

ARTICLE; DRUG FORMULATION; HYDRATION; IN VITRO STUDY; MATRIX TABLET; SUSTAINED DRUG RELEASE;

ACRYLATES; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; LACTOSE; METHYLCELLULOSE; METRONIDAZOLE; SODIUM BICARBONATE; SOLUBILITY; TABLETS;

EID: 33748514588     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040500534127     Document Type: Article

References (29)

1. Bettini, R., Castellani, P. L., Santi, P., Massimo, G., Peppas, N. A. & Colombo, P. (2001). Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate. J. Control. Release., 70, 383-391.
2. Brazel, C. S., & Peppas, N. A. (2000). Modeling of drug release from swellable polymers. Eur. J. Pharm. Biopharm., 49, 47-58.
3. Chikhalikar K., & Moorkath, S. (2003). Carbopol polymers: A versatile range of polymers for pharmaceutical applications. Retrieved December 20, 2003 from PHARMABIZ.com. http://www.pharmabiz.com/articledetnews.asp?articleid= 16723§ionid=50&z=y. December 12, 2002.
4. Efentakis, M., Vlachou, M., & Choulis N. H. (1997). Effects of excipients on swelling and drug release from compressed matrices. Drug Dev. Ind. Pharm., 23, 107-112.
5. Espinoza, R., & Villafuerte, L., (1999). Influence of admixed lactose on pelanserin hydrochloride release from hydroxypropyl methylcellulose matrix tablets. Pharm. Acta Helv., 74, 65-71.
6. Holgado, M. A., Caraballo, I., Alvarez-Fuentes, J., Fernández- Hervás, M. J., Fernández-Arévalo, M. and & Rabasco, A. M., (1995). Influence of diluents and manufacturing method on the in vitro dissolution of carteolol hydrochloride matrix tablets. Int. J. Pharm., 118, 151-160.
7. Katzhendler, I., Hoffman, A., Goldberger, A., & Friedman, M. (1997). Modeling of drug release from erodible tablets. J. Pharm. Sci., 86(1), 110-115.
8. Kavanagh, N., & Corrigan, O. I. (2004). Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices-influence of agitation and dissolution medium composition. Int. J. Pharm. 279(1-2), 141-152.
9. Khan, G. M., & Zhu, J. B. (1999). Studies on drug release kinetics from ibuprofen-carbomer hydrophilic matrix tablets: influence of co-excipients on release rate of the drug. J. Control. Release., 57, 197-203
10. Kibbe, A. H. (Ed.). (2000). Handbook of Pharmaceutical Excipients (3rd ed.). Washington, DC: American Pharmaceutical Association.
11. Kim, H., & Fassihi, R., (1997). Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics. J. Pharm. Sci., 86(3), 323-328.
12. Lapidus, H., & Lordi, N. J., (1968). Drug release from compressed hydrophilic matrices. J. Pharm. Sci., 57, 1292-1301.
13. Li, S., Lin, S., Chien, Y. W., Daggy, B. P., & Mirchandani, H. L. (2001). Statistical optimization of gastric floating system for oral controlled delivery of calcium. AAPS Pharm. Sci. Tech., 2(1), article 1.
14. Li, S., Lin, S., Daggy, B. P., Marchandani, H. L., & Chien, Y. W. (2002). Effect of formulation variables on the floating properties of gastric floating drug delivery system. Drug Dev. Ind. Pharm., 28(7), 783-793.
15. López-Solis, J., & Villafuerte-Robles, L. (2001). Effect of disintegrants with different hygroscopicity on dissolution of Norfloxacin/Pharmatose DCL11 tablets. Int. J. Pharm. 216, 127-135.
16. Mandal, T. K. (1995). The influence of binding solvents on drug release from hydroxypropyl methylcellulose tablets. Drug Dev. Ind. Pharm., 21, 1389-1397.
17. Martínez-González I., & Villafuerte-Robles L. (2003a). Effect of varying the restriction degree of 4-aminopyridine release from HPMC matrices on the mechanism controlling the process. Int. J. Pharm., 257, 253-264.
18. Martínez-González, I., & Villafuerte-Robles, L. (2003b). Influence of enteric citric acid on the release profile of 4-aminopyridine from HPMC matrix tablets. Int. J. Pharm., 251(1-2), 183-193.
19. Martínez-González, I., & Villafuerte-Robles, L. (2004). Influence of enteric lactose on the release profile of 4-aminopyridine from HPMC matrix tablets. Pharm. Dev. Tech., 9(2), 145-153.
20. Ranga Rao, K. V., Padmalatha Devi, K., & Buri, P., (1988). Cellulose matrices for zero-order release of soluble drugs. Drug Dev. Ind. Pharm., 14(15-17), 2299-2320.
21. Rinaki, E., Valsami, G., & Macheras P. (2003). The power law can describe the "entire" drug release curve from HPMC-based matrix tablets: a hypothesis. Int. J. Pharm., 255, 199-207.
22. Risbud, M. V., Hardikar, A. A., Bhat, S. V., & Bhonde, R. R. (2000). pH-sensitive freeze dried chitosan-polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery. J. Control. Release, 68, 23-30.
23. Sheth, P. R., & Tossounian, J. L. (1979). U.S. Patent No. 4,140,755 (pp. 1-2). Washington, DC: U.S. Patent and Trademark Office.
24. Shott, H. (1992). Kinetics of swelling of polymers and their gels. J. Pharm. Sci. 81 (5), 467-470.
25. Singh, B. N., & Kim, K. H. (2000). Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. J. Control. Release, 63, 235-259.
26. Vigoreaux, V., & Ghaly, E. S. (1994). Fickian and relaxational contribution quantification of drug release in a swellable hydrophilic polymer matrix. Drug Dev. Ind. Pharm., 20(16), 2519-2526.
27. Wu, Y., & Fassihi, R. (2005). Stability of metronidazole, tetracycline HCl and famotidine alone and in combination. Int. J. Pharm., 290, 1-13.
28. Xu, G., & Groves, M. J. (2001). Effect of FITC-dextran molecular weight on its release from floating cetyl alcohol and HPMC tablets. J. Pharm. Pharmacol, 53, 49-55.
29. Yang, L., Eshraghi, J., & Fassihi, R. (1999). A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: in vitro evaluation. J. Control. Release, 57, 215-222.